DSM calculates sales of antipyretics, analgesics, and NSAIDs in the first half of 2023


Russian Association of Pharmacy Networks, 20 September 2023

DSM Group has analysed the market of anti-inflammatory, antipyretic, and analgesic drugs for the first half of 2023. According to the released data, the rouble share of Russian-made drugs is growing annually: at the end of the first half of 2023, it amounted to 41%. About 60% of sales are made up of drugs of leading Russian manufacturers.

OTC drugs account for 82% of antipyretics, analgesics, and NSAIDs. The top three drugs in terms of physical consumption are:

acetylsalicylic acid + caffeine + paracetamol (16.1% of all packages), paracetamol (14.4%), acetylsalicylic acid (9.7%).

Pharmstandard is the leader in physical sales, thanks to its first positions in such INNs and combinations as acetylsalicylic acid + caffeine + paracetamol, paracetamol, acetylsalicylic acid, and sodium metamizole (in the price segment of up to 50 roubles per package).

Source: https://raas.ru/2023/09/20/dsm-%d0%be%d1%86%d0%b5%d0%bd%d0%b8%d0%bb%d0%b0-%d0%bf%d1%80%d0%be%d0%b4%d0%b0%d0%b6%d0%b8-%d0%b6%d0%b0%d1%80%d0%be%d0%bf%d0%be%d0%bd%d0%b8%d0%b6%d0%b0%d1%8e%d1%89%d0%b8%d1%85-%d0%be%d0%b1%d0%b5%d0%b7/

Back Print out